Leaflet OXSORALEN 10mg soft capsules

Indicated for: psoriasis; vitiligo

Route of administration: oral

Substance: methoxalen (immunomodulator)

ATC: D05BA02 (Dermatologicals | Antipsoriatics for systemic use | Psoralens for systemic use)

Precautions:
Avoid live vaccines
Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Immunosuppression / infection risk
Immunosuppression / infection risk

This medicine may increase the risk of infections.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Methoxsalen is a medication used to treat certain dermatological and skin conditions, such as severe psoriasis, vitiligo, and cutaneous T-cell lymphoma. It belongs to a class of drugs called psoralens and is used in combination with ultraviolet A (UVA) radiation therapy, known as PUVA therapy (Psoralen + UVA).

Methoxsalen works by increasing the skin's sensitivity to UVA radiation. After taking the medication, exposure to UVA light triggers a photochemical reaction that slows the growth of skin cells and reduces inflammation. This mechanism is beneficial in treating conditions characterized by excessive skin cell growth or loss of pigmentation.

The medication is available in oral capsules or topical solutions, depending on the condition being treated. In PUVA therapy, methoxsalen is administered a few hours before UVA exposure. The dosage and frequency of treatment are determined by the doctor based on the severity of the condition and the patient’s response.

Common side effects include nausea, skin redness, itching, or a burning sensation. In rare cases, more serious adverse effects such as severe sunburn, premature skin aging, or an increased risk of skin cancer may occur. It is essential for patients to avoid excessive sun exposure and use sunscreen.

Methoxsalen is contraindicated in patients with photosensitive skin disorders, skin cancer, or severe liver disease. It is important for the treatment to be conducted under the supervision of a specialist, and patients must strictly follow instructions to minimize associated risks.

General data about OXSORALEN 10mg

  • Substance: methoxalen
  • Date of latest medicines list: 01-07-2013
  • Product code: W43974001
  • Concentration: 10mg
  • Pharmaceutical form: soft capsules
  • Quantity: 50
  • Product type: Original
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.